| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Shanghai Bio-heart Biological Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.86 |
| 52 Week High | HK$7.65 |
| 52 Week Low | HK$1.80 |
| Beta | -0.47 |
| 1 Month Change | -21.85% |
| 3 Month Change | -37.79% |
| 1 Year Change | -72.89% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -90.75% |
Recent News & Updates
Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth
Feb 22
Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth
Nov 03Recent updates
Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth
Feb 22Companies Like Shanghai Bio-heart Biological Technology (HKG:2185) Are In A Position To Invest In Growth
Nov 03We Think Shanghai Bio-heart Biological Technology (HKG:2185) Can Afford To Drive Business Growth
May 12We're Not Worried About Shanghai Bio-heart Biological Technology's (HKG:2185) Cash Burn
Sep 19Shanghai Bio-heart Biological Technology (HKG:2185) Is In A Good Position To Deliver On Growth Plans
Jun 03Shareholder Returns
| 2185 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | -7.9% | 2.4% | 2.3% |
| 1Y | -72.9% | -50.6% | -10.9% |
Return vs Industry: 2185 underperformed the Hong Kong Medical Equipment industry which returned -50.6% over the past year.
Return vs Market: 2185 underperformed the Hong Kong Market which returned -10.9% over the past year.
Price Volatility
| 2185 volatility | |
|---|---|
| 2185 Average Weekly Movement | 9.8% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 14.5% |
| 10% least volatile stocks in HK Market | 3.7% |
Stable Share Price: 2185's share price has been volatile over the past 3 months.
Volatility Over Time: 2185's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 32 | Philip Wang | www.bio-heart.com |
Shanghai Bio-heart Biological Technology Co., Ltd. operates as an interventional cardiovascular device company in the People’s Republic of China. The company focuses on the provision of bioresorbable scaffolds (BRS) and renal denervation (RDN) therapies for the treatment of coronary artery diseases and uncontrolled and resistant hypertension.
Shanghai Bio-heart Biological Technology Co., Ltd. Fundamentals Summary
| 2185 fundamental statistics | |
|---|---|
| Market cap | HK$452.76m |
| Earnings (TTM) | -HK$190.13m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.4x
P/E RatioIs 2185 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2185 income statement (TTM) | |
|---|---|
| Revenue | CN¥0 |
| Cost of Revenue | CN¥0 |
| Gross Profit | CN¥0 |
| Other Expenses | CN¥175.89m |
| Earnings | -CN¥175.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.72 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did 2185 perform over the long term?
See historical performance and comparison